Breaking News
FONT-SIZE Plus   Neg
Share SHARE

Colgate Palmolive Declares 900% Third Interim Dividend For FY13

Colgate Palmolive (India) Ltd. said its board had declared an interim dividend of 900 percent or Re.9.00 per equity share of Rs.1 each for the fiscal year 2013.

The company fixed April 5 as the Record Date for the purpose of payment of interim dividend and it will be paid on April 19, 2013.

The company reported third-quarter net profit of Rs.111 crore, compared with Rs.116 crore in the third-quarter of last year, reflecting a four percent decline. Total income increased by 14 percent to Rs.796 crore from the Rs.701 crore in the year-ago quarter.

At the BSE, Colgate Palmolive (India) shares are currently trading at Rs.1,291, down 1.40 percent from the previous close.

Click here to receive FREE breaking news email alerts for Colgate-Palmolive (India) Ltd. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Computer and printer maker Hewlett-Packard Co. said Tuesday after the markets closed that its fourth quarter profit fell 6% from last year, as revenue declined 2%. The company's quarterly earnings per share, excluding items, came in line with analysts' expectations, but its quarterly revenue fell short of analysts' forecast. This organic and natural products company has experienced strong compounded annual growth over the last four fiscal years with its net sales growing 25% and adjusted income from continuing operations over 30%. Here is a quick summary of the earnings reported after the bell on Nov. 24. 1. Amira Nature Foods Ltd (ANFI) reported net income for the second quarter of $8.3 million or $0.29 per share, compared to $5.0 million or $0.18 per share for the year-ago quarter. Excluding items, adjusted earnings...
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.